Pharmacokinetic Parameters of Ranolazine At hours post-dose: 0, 2, 4, 8, 12, 15, 18, 20, 22, 23, 26, 30, 65 [clinicaltrials_resource:c1251b7dc071b3fd016786012409e63f]
Peak Plasma Concentration (Cmax) with a 500 mg dose of ranolazine
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Pharmacokinetic Parameters of Ranolazine At hours post-dose: 0, 2, 4, 8, 12, 15, 18, 20, 22, 23, 26, 30, 65 [clinicaltrials_resource:c1251b7dc071b3fd016786012409e63f]
Peak Plasma Concentration (Cmax) with a 500 mg dose of ranolazine
Bio2RDF identifier
c1251b7dc071b3fd016786012409e63f
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:c1251b7dc071b3fd016786012409e63f
measure [clinicaltrials_vocabulary:measure]
Pharmacokinetic Parameters of Ranolazine
time frame [clinicaltrials_vocabulary:time-frame]
At hours post-dose: 0, 2, 4, 8, 12, 15, 18, 20, 22, 23, 26, 30, 65
description
Peak Plasma Concentration (Cmax) with a 500 mg dose of ranolazine
identifier
clinicaltrials_resource:c1251b7dc071b3fd016786012409e63f
title
Pharmacokinetic Parameters of ...... 15, 18, 20, 22, 23, 26, 30, 65
@en
type
label
Pharmacokinetic Parameters of ...... 51b7dc071b3fd016786012409e63f]
@en